-+ 0.00%
-+ 0.00%
-+ 0.00%

EM Systems (TSE:4820) Stock Price Mirrors Margin Squeeze And Thin Dividend Cover

Simply Wall St·08/12/2026 08:33:15
Listen to the news

EM Systems heads into this earnings season with the stock at ¥559, up modestly over the past month but still lower over the last quarter. The headline today is not revenue; it is profitability. Trailing net profit margin sits at 6.9% compared with 11.7% a year earlier, while the stock trades on a P/E of 25.6x and carries a 4.11% dividend that is not well covered by earnings or free cash flow.

For you as an investor, the question is how comfortable you are with paying up for EM Systems while margins and dividend cover look tight.

Is EM Systems trading at a justifiable premium on 25.6x trailing P/E with a 4.11% dividend that lacks strong cover, or is the market misreading the margin story? See how current earnings, cash flows and multiples line up in the full valuation analysis for EM Systems

H1 2026 Earnings Summary

  • Revenue (H1 2026 vs. H1 2025): ¥10,434 million vs. ¥12,149 million (change reflects lower half year revenue)
  • Net Income (Excl. Extra Items, H1 2026 vs. H1 2025): ¥663 million vs. ¥1,603 million (change reflects lower half year earnings)
  • Basic EPS (H1 2026 vs. H1 2025): ¥9.58 vs. ¥23.18 (change reflects lower earnings per share for the half)
  • Trailing 12-Month Net Profit Margin (Latest vs. Prior Year): 6.9% vs. 11.7% (margin compression over the last 12 months, including impact from a one off loss of ¥776 million)

Prefer clear visuals instead of scrolling through dense earnings tables and dividend figures for EM Systems? View the full picture of its dividend history in an easy-to-scan visual dashboard via our company report for EM Systems.

TSE:4820 Trailing 12-Month Earnings & Revenue History as at Aug 2026
TSE:4820 Trailing 12-Month Earnings & Revenue History as at Aug 2026

EM Systems bullish story meets mixed reality

For investors attracted to EM Systems as a steady healthcare IT backbone, the latest figures send a more cautious signal. Recurring, mission critical pharmacy and clinic systems may still support the long term story, but the immediate picture is softer. Revenue for H1 2026 of ¥10,434 million sits below the prior half. Net income excluding extra items is ¥663 million, well under the previous ¥1,603 million. The core business remains tied to essential healthcare workflows, yet current earnings momentum does not give clear support to a strong bullish angle.

Margin pressure strengthens the cautious EM Systems view

Bearish arguments around pressure on profitability and dividend cover currently find more backing in the numbers. Trailing net profit margin is 6.9% compared with 11.7% a year earlier after a one off loss of ¥776 million. Basic EPS for H1 2026 is ¥9.58 versus ¥23.18 in H1 2025, which points to weaker earnings power despite EM Systems operating in essential end markets. Revenue has eased and profits have compressed, so near term financial trends leave less room for error in the margin and payout story.

After weaker margins, a 4.11% dividend that lacks strong cover and one-off losses, you may want to review whether these are isolated issues or part of a deeper pattern. Scan the independent risk analysis for EM Systems which shows 3 important warning signs

Stay Ahead Of Your Next Move

With EM Systems balancing tighter margins and a dividend that lacks strong cover, it can help to wait for the right entry point rather than rush in. Register for free with Simply Wall St and add EM Systems to your Watchlist to track price versus fair value and keep an eye on how its earnings story evolves. If you already hold the stock, use the Portfolio Command Center to cut through market noise and focus on the most important developments for your holdings. Then tap into the collective insights on our Community so you can spot potential catalysts or risks early and stay a step ahead of the wider market.

Seeking Alternatives Beyond EM Systems?

Fresh ideas move fast and the strongest stories often gain momentum before the crowd notices. Spot potential breakouts while it matters and before they are fully priced. Act now.

  • Spot resilient cash generators before they start flying by scanning our curated list of solid balance sheet and fundamentals stocks (41 results). This highlights companies with stronger foundations than the headlines suggest.
  • Catch potential income workhorses while yields remain under the radar for now by reviewing the hand picked 37 dividend fortresses. This prioritises durability over short lived hype.
  • Track potential AI suppliers supporting the next leg of computing momentum through a focused shortlist in the 57 AI infrastructure stocks. This surfaces real businesses, not just stories.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.